GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ContextVision AB (OSTO:COVo) » Definitions » Capital Expenditure

ContextVision AB (OSTO:COVO) Capital Expenditure : kr4.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is ContextVision AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

ContextVision AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr0.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr4.63 Mil.


ContextVision AB Capital Expenditure Historical Data

The historical data trend for ContextVision AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ContextVision AB Capital Expenditure Chart

ContextVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.84 -8.90 -4.61 -4.60 -0.84

ContextVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.24 -0.67 -1.25 6.56 -

ContextVision AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ContextVision AB (OSTO:COVO) Business Description

Traded in Other Exchanges
Address
Klara Norra Kyrkogata 31, Stockholm, SWE, SE-111 22
ContextVision AB is a Sweden-based medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.

ContextVision AB (OSTO:COVO) Headlines

No Headlines